JP2017530088A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530088A5
JP2017530088A5 JP2016572236A JP2016572236A JP2017530088A5 JP 2017530088 A5 JP2017530088 A5 JP 2017530088A5 JP 2016572236 A JP2016572236 A JP 2016572236A JP 2016572236 A JP2016572236 A JP 2016572236A JP 2017530088 A5 JP2017530088 A5 JP 2017530088A5
Authority
JP
Japan
Prior art keywords
xaa
peptide
composition
product
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572236A
Other languages
English (en)
Japanese (ja)
Other versions
JP6698556B2 (ja
JP2017530088A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/034859 external-priority patent/WO2015191551A1/en
Publication of JP2017530088A publication Critical patent/JP2017530088A/ja
Publication of JP2017530088A5 publication Critical patent/JP2017530088A5/ja
Application granted granted Critical
Publication of JP6698556B2 publication Critical patent/JP6698556B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572236A 2014-06-09 2015-06-09 抗微生物性ペプチド、その医薬組成物および使用方法 Active JP6698556B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462009467P 2014-06-09 2014-06-09
US62/009,467 2014-06-09
PCT/US2015/034859 WO2015191551A1 (en) 2014-06-09 2015-06-09 Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2017530088A JP2017530088A (ja) 2017-10-12
JP2017530088A5 true JP2017530088A5 (enExample) 2018-07-19
JP6698556B2 JP6698556B2 (ja) 2020-05-27

Family

ID=53443015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572236A Active JP6698556B2 (ja) 2014-06-09 2015-06-09 抗微生物性ペプチド、その医薬組成物および使用方法

Country Status (6)

Country Link
US (2) US10118948B2 (enExample)
EP (1) EP3152224B1 (enExample)
JP (1) JP6698556B2 (enExample)
AU (1) AU2015274889B2 (enExample)
CA (1) CA2951386C (enExample)
WO (1) WO2015191551A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015274889B2 (en) 2014-06-09 2019-01-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof
WO2019028463A1 (en) * 2017-08-04 2019-02-07 Bioventures, Llc LINEAR LIPOPEPTIDE PAENIPEPTINS AND METHODS OF USE
EP4192847A1 (en) * 2020-08-10 2023-06-14 Università Cattolica del Sacro Cuore New antimicrobial peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762928A (en) 1997-06-05 1998-06-09 Campbell Soup Company Biocontrol agent for green mold disease of mushrooms
WO2006099306A2 (en) 2005-03-10 2006-09-21 Custom Medical Applications, Inc. Catheter connection hub
UA15147U (en) 2005-12-20 2006-06-15 Instex And Clinical Veterinary ôLACTOSPORö, A COMPLEX AGENT FOR PROPHYLAXIS AND TREATMENT OF CALVES GASTROINTESTINAL DISEASES
ATE505197T1 (de) 2006-09-28 2011-04-15 Univ Ohio State Res Found Antibiotische und antimikrobielle wirkstoffe sowie verfahren zu ihrer verwendung
MX356959B (es) 2011-05-20 2018-06-21 The Us Secretary Department Of Health & Human Services Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
WO2013086003A1 (en) * 2011-12-05 2013-06-13 The Ohio State University Antimicrobial agent, bacterial strain, biosynthesis, and methods of use
AU2015274889B2 (en) 2014-06-09 2019-01-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

Similar Documents

Publication Publication Date Title
JP7267251B2 (ja) 抗菌組成物及び医薬組成物
RU2695455C2 (ru) Противомикробный пептид
KR101306643B1 (ko) 항미생물성 헥사펩티드
US9315548B2 (en) Peptoid oligomers, pharmaceutical compositions and methods of using the same
US10363282B2 (en) Analogs of C5a and methods of using same
Su et al. Progress in the classification, optimization, activity, and application of antimicrobial peptides
RU2699712C1 (ru) Антимикробный пептид и его применение
AU2012210564B2 (en) Human lactoferrin based peptides having antiinflammatory activity
JP2019533722A5 (enExample)
US20140314839A1 (en) Controlled-release peptide compositions and uses thereof
CN101333247B (zh) 从东北林蛙皮肤中分离出的抗菌肽及其在抗菌药物中的应用
AU2012210564A1 (en) Human lactoferrin based peptides having antiinflammatory activity
JPWO2013180011A1 (ja) 抗菌ペプチド及びその利用
US9545461B2 (en) Anti-microbial peptides and methods of use thereof
CN102766196B (zh) 一组阳离子抗菌肽及其制备方法和应用
WO2018031730A3 (en) Peptide inhibitors of phosphoglycerate mutase and methods of use
WO2009005798A3 (en) Antifungal formulation and method of preparation
WO2023075675A1 (en) Antibacterial peptide
JPH03504501A (ja) 両親媒性ペプチドとその用途
KR20180086277A (ko) 폴리펩티드 화합물, 그리고 이의 제조 방법 및 적용
JP2017530088A (ja) 抗微生物性ペプチド、その医薬組成物および使用方法
CN120665144B (zh) 一种n-末端脂肪酸修饰的抗菌肽类似物及其用途
KR101209344B1 (ko) 쯔쯔가무시 균의 감염 또는 증식 저해 활성을 가지는 펩티드 화합물 및 이를 이용한 쯔쯔가무시증 개선용 약제학적 조성물
US20240254175A1 (en) Novel selective antimicrobial fusion peptides
Stawikowski et al. Lipodepsipeptide antibiotic fusaricidin and its analogues. Total solid-phase and biological activity.